Tivic Health Systems Inc. has entered into a significant Securities Purchase Agreement with an investor on April 29, 2025. Under the agreement, Tivic will sell up to 8,400 shares of its newly designated Series B Non-Voting Convertible Preferred Stock, along with warrants to purchase common stock, for a total potential investment of $8.4 million. The sales will occur in multiple tranche closings, with a deadline for completion set for December 31, 2025. The agreement includes a Registration Rights Agreement, requiring Tivic to file a registration statement within 15 days to facilitate the resale of securities by the investor. However, investor conversions and warrant exercises are capped at 19.99% of Tivic's outstanding common stock as of the agreement date until stockholder approval is obtained.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.